On January 17, 2023, Shao-Lee Lin, M.D., Ph.D., notified the Board of Directors of Third Harmonic Bio, Inc. of her decision to resign as a Class II director of the Board, and as Chairperson of the Nominating and Governance Committee of the Board, in each case effective as of January 17, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.4 USD | -1.83% | -4.22% | +22.15% |
05-20 | Third Harmonic Bio Insider Sold Shares Worth $331,066, According to a Recent SEC Filing | MT |
05-15 | Third Harmonic Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.15% | 559M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- THRD Stock
- News Third Harmonic Bio, Inc.
- Third Harmonic Bio, Inc. Announces Resignation of Shao-Lee Lin as Class II Director and Chairperson of the Nominating and Governance Committee of the Board